The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder.

Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982 · see citing works

Regulatory T Cells and Immune Tolerance

Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,357 · see citing works

Bipolar Disorder

Yatham, L. N., & Malhi, G. S. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,515 · see citing works

Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis

Christopherson, K. S., Ullian, E. M., Stokes, C. C. A., Mullowney, C. E., Hell, J. W., Agah, A., Lawler, J., Mosher, D. F., Bornstein, P., & Barres, B. A. (2005) · Cell · doi:10.1016/j.cell.2004.12.020 · Cited by 1,688 · see citing works

The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review

Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0597 · Cited by 995 · see citing works

Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review

Potvin, S., Stip, É., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, É. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 989 · see citing works

Overexpression of Monocyte Chemoattractant Protein-1 in Adipose Tissues Causes Macrophage Recruitment and Insulin Resistance

Kamei, N., Tobe, K., Suzuki, R., Ohsugi, M., Watanabe, T., Kubota, N., Ohtsuka-Kowatari, N., Kumagai, K., Sakamoto, K. Q., Kobayashi, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601284200 · Cited by 918 · see citing works

Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide

Steiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., Bernstein, H.-G., & Bogerts, B. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.10.013 · Cited by 791 · see citing works

Aging and proinflammatory cytokines

Bruunsgaard, H., Pedersen, M., & Pedersen, B. K. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200105000-00001 · Cited by 690 · see citing works

QUINOLINIC ACID AND KYNURENINE PATHWAY METABOLISM IN INFLAMMATORY AND NON-INFLAMMATORY NEUROLOGICAL DISEASE

Heyes, M. P., Saito, K., Crowley, J. S., DAVIS, L. E., Demitrack, M. A., Der, M. G., Dilling, L. A., Elia, J., Kruesi, M. J. P., Lackner, A. A., et al. (1992) · Brain · doi:10.1093/brain/115.5.1249 · Cited by 682 · see citing works

ICAM-1 signaling in endothelial cells

Lawson, C., & Wolf, S. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70004-0 · Cited by 670 · see citing works

Microglia in health and disease

Kim, S. U., & de Vellis, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20562 · Cited by 663 · see citing works

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

Mellor, A. L., & Munn, D. H. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01520-0 · Cited by 647 · see citing works

Antipsychotic-induced weight gain: a review of the literature.

Allison, D. B., & Casey, D. E. (2001) · PubMed · Cited by 596 · see citing works

Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study

van Berckel, B. N. M., Bossong, M. G., Boellaard, R., Kloet, R. W., Schuitemaker, A., Caspers, E., Luurtsema, G., Windhorst, A. D., Cahn, W., Lammertsma, A. A., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.025 · Cited by 582 · see citing works

Microglial control of neuronal death and synaptic properties

Bessis, A., Béchade, C., Bernard, D., & Roumier, A. (2006) · Glia · doi:10.1002/glia.20459 · Cited by 454 · see citing works

Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder

Kauer‐Sant’Anna, M., Kapczinski, F. P., Andreazza, A. C., Bond, D. J., Lam, R. W. M., Young, L. T., & Yatham, L. N. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009310 · Cited by 434 · see citing works

Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder

Brietzke, E., Stertz, L., Fernandes, B. S., Kauer-Sant’Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J. A., & Kapczinski, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.001 · Cited by 423 · see citing works

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

Frommberger, U. H., Bauer, J., Haselbauer, P., Fräulin, A., Riemann, D., & Berger, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900219 · Cited by 362 · see citing works

Developmental Neuronal Death in Hippocampus Requires the Microglial CD11b Integrin and DAP12 Immunoreceptor

Wakselman, S., Béchade, C., Roumier, A., Bernard, D., Triller, A., & Bessis, A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1006-08.2008 · Cited by 351 · see citing works

Increase in HLA-DR Immunoreactive Microglia in Frontal and Temporal Cortex of Chronic Schizophrenics

Radewicz, K., Garey, L. J., Gentleman, S. M., & Reynolds, R. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.2.137 · Cited by 341 · see citing works

Gender and autoimmunity

Zandman‐Goddard, G., Peeva, E., & Shoenfeld, Y. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.10.001 · Cited by 338 · see citing works

A Discriminating Messenger RNA Signature for Bipolar Disorder Formed by an Aberrant Expression of Inflammatory Genes in Monocytes

Padmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336 · see citing works

The main function of IL-2 is to promote the development of T regulatory cells

Malek, T. R. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603272 · Cited by 330 · see citing works

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis

Haack, M., Hinze‐Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329 · see citing works

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6

Lin, A., Kenis, G., Bignotti, S., Tura, G. J. B., Jong, R. D., Bosmans, E., Pioli, R., Altamura, C. A., Scharpé, S., & Maes, M. H. J. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00034-6 · Cited by 321 · see citing works

Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial

Akhondzadeh, S., Tabatabaee, M., AMINI, H., Ahmadi-Abhari, S.-A., ABBASI, S., & BEHNAM, B. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.016 · Cited by 290 · see citing works

Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.

O'Brien, S. M., Scully, P., Scott, L. V., & Dinan, T. G. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.11.015 · Cited by 285 · see citing works

Medical Risk in Patients With Bipolar Disorder and Schizophrenia

Newcomer, J. W. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.1106e16 · Cited by 264 · see citing works

S100B in neuropathologic states: The CRP of the brain?

Sen, J., & Belli, A. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21211 · Cited by 258 · see citing works

Immune variations in bipolar disorder: phasic differences

Ortiz‐Domínguez, A., Hernández, M. E., Berlanga, C., Gutiérrez‐Mora, D., Moreno, J., Heinze, G., & Pavón, L. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00493.x · Cited by 255 · see citing works

Cytokines in schizophrenia and the effects of antipsychotic drugs

Drzyzga, Ł. R., Obuchowicz, E., Marcinowska, A., & Herman, Z. S. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.02.002 · Cited by 242 · see citing works

Adipose Tissue and Adipokines—Energy Regulation from the Human Perspective

Trayhurn, P., Bing, C., & Wood, I. S. (2006) · Journal of Nutrition · doi:10.1093/jn/136.7.1935s · Cited by 242 · see citing works

Immune‐inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

Maes, M. H. J., Meltzer, H. Y., & Bosmans, E. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01527.x · Cited by 237 · see citing works

Soluble intercellular adhesion molecule-1 (sICAM-1): an overview.

Witkowska, A. M., & Borawska, M. H. (2004) · PubMed · Cited by 232 · see citing works

The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs.

Kim, Y.-K., Suh, I.-B., Kim, H., Han, C.-S., Lim, C.-S., Choi, S.-H., & Licinio, J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001084 · Cited by 224 · see citing works

The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence

Smith, R. S., & Maes, M. H. J. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90062-4 · Cited by 222 · see citing works

Cortisol and Cytokines in Chronic and Treatment-Resistant Patients with Schizophrenia: Association with Psychopathology and Response to Antipsychotics

Zhang, X. Y., Zhou, D. F., Cao, L. Y., Wu, G. Y., & Shen, Y. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300756 · Cited by 208 · see citing works

A Unique Role of Monocyte Chemoattractant Protein 1 among Chemokines in Adipose Tissue of Obese Subjects

Dahlman, I. A., Kaaman, M., Olsson, T., Tan, G. D., Bickerton, A. S. T., Wåhlén, K., Andersson, J. S. O., Nordström, E. A., Blomqvist, L., Sjögren, A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0369 · Cited by 207 · see citing works

Absence of Neurodegeneration and Neural Injury in the Cerebral Cortex in a Sample of Elderly Patients With Schizophrenia

Arnold, S. E., Trojanowski, J. Q., Gur, R. E., Blackwell, P., Han, L., & Choi, C. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.3.225 · Cited by 199 · see citing works

Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology

Zhang, X. Y., Zhou, D. F., Zhang, P. Y., Wu, G. Y., Cao, L. Y., & Shen, Y. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00296-1 · Cited by 199 · see citing works

Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations?

Bots, M. L., Baldassarre, D., Simon, A. C., de Groot, E., O’Leary, D. H., Riley, W. A., Kastelein, J. J. P., & Grobbee, D. E. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl482 · Cited by 194 · see citing works

Regulatory T cells

THOMPSON, C. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.05.001 · Cited by 192 · see citing works

Minireview: Neuro-Immuno-Endocrine Modulation of the Hypothalamic-Pituitary-Adrenal (HPA) Axis by gp130 Signaling Molecules

Chesnokova, V., & Melmed, S. K. (2002) · Endocrinology · doi:10.1210/endo.143.5.8861 · Cited by 188 · see citing works

Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients

Theodoropoulou, S., Spanakos, G., Baxevanis, C. N., Economou, M., Gritzapis, A. D., Papamichail, M., & Stefanis, C. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00007-4 · Cited by 187 · see citing works

Th1, Th2 and Th3 cytokine alteration in schizophrenia

Kim, Y., Myint, A.-M., Lee, B.-H., Han, C.-S., Lee, H., Kim, D.-J., & Leonard, B. E. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.047 · Cited by 187 · see citing works

The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia

Song, X., Lv, L., Li, W., Hao, Y., & Zhao, J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.018 · Cited by 187 · see citing works

Changes in Serum Interleukin-2, -6, and -8 Levels Before and During Treatment With Risperidone and Haloperidol

Zhang, X., Zhou, D. F., Cao, L. Y., Zhang, P. Y., Wu, G. Y., & Shen, Y. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0710 · Cited by 183 · see citing works

Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics

Kim, Y., Kim, L., & Lee, M. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00171-1 · Cited by 159 · see citing works

Rolipram in Major Depressive Disorder: Results of a Double-Blind Comparative Study with Imipramine

Hebenstreit, G. F., Fellerer, K., Fichte, K., Fischer, G., Geyer, N., Meya, U., Sastre-y-Hernández, M., Schöny, W., Schratzer, M., Soukop, W., et al. (1989) · Pharmacopsychiatry · doi:10.1055/s-2007-1014599 · Cited by 159 · see citing works

Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics

Maes, M. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00062-0 · Cited by 156 · see citing works

Exposure-dependent effects of ethanol on the innate immune system

Goral, J., Karavitis, J., & Kovacs, E. J. (2008) · Alcohol · doi:10.1016/j.alcohol.2008.02.003 · Cited by 152 · see citing works

A comprehensive macrophage-T-lymphocyte theory of schizophrenia

Smith, R. S. (1992) · Medical Hypotheses · doi:10.1016/0306-9877(92)90117-u · Cited by 151 · see citing works

Mood Alterations During Interferon-Alfa Therapy in Patients With Chronic Hepatitis C

Constant, A., Castéra, L., Dantzer, R., Couzigou, P., de Lédinghen, V., Demotes‐Mainard, J., & Henry, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0814 · Cited by 151 · see citing works

High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder

Breunis, M. N., Kupka, R., Nolen, W. A., Suppes, T. M., Denicoff, K. D., Leverich, G. S., Post, R. M., & Drexhage, H. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01452-x · Cited by 149 · see citing works

Elevated Interleukin-6 in the Cerebrospinal Fluid of a Previously Delineated Schizophrenia Subtype

Garver, D. L., Tamas, R. L., & Holcomb, J. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300217 · Cited by 146 · see citing works

A differential role for interleukin-6 and tumor necrosis factor-α in schizophrenia?

Naudin, J., Capo, C., Giusano, B., Mège, J. L., & Azorin, J. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00059-5 · Cited by 141 · see citing works

Cytokine Changes and Tryptophan Metabolites in Medication-Naïve and Medication-Free Schizophrenic Patients

Kim, Y., Myint, A.-M., Verkerk, R. M., Scharpé, S., Steinbusch, H. W. M., & Leonard, B. E. (2009) · Neuropsychobiology · doi:10.1159/000213565 · Cited by 136 · see citing works

Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment

Monteleone, P., Fabrazzo, M., Tortorella, A. A. V., & Maj, M. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)00036-x · Cited by 134 · see citing works

Expression of CD40 in the brain of Alzheimer’s disease and other neurological diseases

Togo, T., Akiyama, H., Kondo, H., Ikeda, K., Kato, M., Iseki, E., & Kosaka, K. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02984-x · Cited by 131 · see citing works

[11C]-DPA-713 and [18F]-DPA-714 as New PET Tracers for TSPO: A Comparison with [11C]-(R)-PK11195 in a Rat Model of Herpes Encephalitis

Doorduin, J., Klein, H. C., Dierckx, R., James, M. L., Kassiou, M., & de Vries, E. F. J. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0211-6 · Cited by 131 · see citing works

Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia

Müller, N., Empl, M., Riedel, M. J., Schwarz, M., & Ackenheil, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02922260 · Cited by 127 · see citing works

Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics.

Wierzba‐Bobrowicz, T., Lewandowska, E., Lechowicz, W., Stępień, T., & Pasennik, E. (2005) · PubMed · Cited by 113 · see citing works

Serum IL‐1β, sIL‐2R, IL‐6, IL‐8 and TNF‐α in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment

Erbağcı, A. B., Herken, H., Köylüoğlu, O., Yılmaz, N., & Tarakçıoğlu, M. (2001) · Mediators of Inflammation · doi:10.1080/09629350123895 · Cited by 113 · see citing works

Association between the A?2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus

Simeoni, E., Hoffmann, M. M., Winkelmann, B. R., Ruiz, J., Fleury, S., Boehm, B. O., M�rz, W., & Vassalli, G. (2004) · Diabetologia · doi:10.1007/s00125-004-1494-4 · Cited by 109 · see citing works

Immunological Dysfunction in Schizophrenia: A Systematic Approach

Rothermundt, M., Arolt, V., Weitzsch, C., Eckhoff, D., & Kirchner, H. (1998) · Neuropsychobiology · doi:10.1159/000026501 · Cited by 104 · see citing works

T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients.

Kim, Y.-K., Myint, A.-M., Lee, B.-H., Han, C.-S., Lee, S.-W., Leonard, B. E., & Steinbusch, H. W. M. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.08.005 · Cited by 100 · see citing works

Metabolic syndrome and schizophrenia

Thakore, J. H. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.6.455 · Cited by 100 · see citing works

Accumulation of Macrophages in the CSF of Schizophrenic Patients During Acute Psychotic Episodes

̄, H. V. N., ⁄, K. M., Ahokas, A., Miettinen, K., Rimón, R., & Andersson, L. C. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1725 · Cited by 98 · see citing works

Spatial arrangement of microglia in the mouse hippocampus: A stereological study in comparison with astrocytes

Jinno, S., Fleischer, F., Eckel, S., Schmidt, V., & Kosaka, T. (2007) · Glia · doi:10.1002/glia.20552 · Cited by 98 · see citing works

Decreased levels of soluble intercellular adhesion Molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients

Schwarz, M., Riedel, M. J., Ackenheil, M., & Müller, N. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00206-1 · Cited by 96 · see citing works

Macrophages in the murine pancreas and their involvement in fetal endocrine development in vitro

Geutskens, S. B., Otonkoski, T., Pulkkinen, M.-A., Drexhage, H. A., & Leenen, P. J. M. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1004624 · Cited by 96 · see citing works

Altered T-Cell Function in Schizophrenia: A Cellular Model to Investigate Molecular Disease Mechanisms

Craddock, R. M., Lockstone, H. E., Rider, D. A., Wayland, M. T., Harris, L. J. W., McKenna, P. J., & Bahn, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000692 · Cited by 95 · see citing works

The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: Novel hypothesis-driven treatments for bipolar depression?

Soczynska, J. K., Kennedy, S. H., Goldstein, B. I., Lachowski, A. M., Woldeyohannes, H. O., & McIntyre, R. S. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.03.004 · Cited by 93 · see citing works

Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia

O’Brien, S. M., Scully, P., & Dinan, T. G. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.11.014 · Cited by 93 · see citing works

T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patients

Sperner‐Unterweger, B., Whitworth, A. B., Kemmler, G., Hilbe, W., Thaler, J., Weiß, G., & Fleischhacker, W. W. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00175-3 · Cited by 86 · see citing works

Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients.

Hori, H., Yoshimura, R., Yamada, Y., Ikenouchi, A., Mitoma, M., Ida, Y., & Nakamura, J. (2007) · PubMed · doi:10.1097/yic.0b013e3280103593 · Cited by 83 · see citing works

Increased serum levels of CCL11/eotaxin in schizophrenia

Teixeira, A. L., Reis, H. J., Nicolato, R., Brito-Melo, G., Corrêa, H., Teixeira, M. M., & Romano‐Silva, M. A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.11.019 · Cited by 83 · see citing works

The Phosphodiesterase Inhibitors Pentoxifylline and Rolipram Suppress Macrophage Activation and Nitric Oxide Production in Vitro and in Vivo

Beshay, E., Croze, F., & Prud’homme, G. J. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4964 · Cited by 81 · see citing works

Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics

Zhang, X. Y., Zhou, D. F., Qi, L. Y., Chen, S., Cao, L. Y., Chen, D. C., Xiu, M. H., Wang, F., Wu, G. Y., Lü, L., et al. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1447-6 · Cited by 81 · see citing works

Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia

Falke, E., Han, L.-Y., & Arnold, S. E. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00104-9 · Cited by 77 · see citing works

Immunohistochemical detection of thrombospondin in microglia in the developing rat brain

Chamak, B., Dobbertin, A., & Mallat, M. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00236-c · Cited by 77 · see citing works

Dendritic cells and macrophages in the pituitary and the gonads. Evidence for their role in the fine regulation of the reproductive endocrine response

Hoek, A., Allaerts, W., Leenen, P., Schoemaker, J., & Drexhage, H. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1360008 · Cited by 74 · see citing works

Antiviral and immunomodulatory effect of lithium.

Rybakowski, J. K. (2000) · PubMed · Cited by 72 · see citing works

Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients.

Kamińska, T., Wysocka, A., Marmurowska-Michałowska, H., Dubas-Ślemp, H., & Kandefer‐Szerszeń, M. (2001) · PubMed · Cited by 72 · see citing works

Distinct Monocyte Gene-Expression Profiles in Autoimmune Diabetes

Padmos, R. C., Schloot, N. C., Beyan, H., Ruwhof, C., Staal, F. J. T., de Ridder, D., Aanstoot, H., Lam‐Tse, W., de Wit, H., Herder, C., et al. (2008) · Diabetes · doi:10.2337/db08-0496 · Cited by 71 · see citing works

T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment

Maino, K., Gruber, R., Riedel, M. J., Seitz, N., Schwarz, M., & Müller, N. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.06.004 · Cited by 70 · see citing works

Increased Serum Levels of Inflammatory Markers in Chronic Institutionalized Patients with Schizophrenia

Coelho, F. M., Reis, H. J., Nicolato, R., Romano‐Silva, M. A., Teixeira, M. M., Bauer, M. E., & Teixeira, A. L. (2008) · NeuroImmunoModulation · doi:10.1159/000148197 · Cited by 66 · see citing works

T-lymphocyte subpopulations in schizophrenic patients

Henneberg, A. E., Riedl, B., Dumke, H. O., & Kornhuber, H. H. (1990) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf01735051 · Cited by 62 · see citing works

Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease?

Zorrilla, E. P., Cannon, T. D., Gur, R. E., & Kessler, J. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00598-6 · Cited by 57 · see citing works

Interleukin-12 plasma levels in drug-naïve patients with a first episode of psychosis: Effects of antipsychotic drugs

Crespo‐Facorro, B., Carrasco-Marı́n, E., Pérez‐Iglesias, R., Pelayo‐Terán, J. M., Fernández-Prieto, L., Leyva‐Cobián, F., & Vázquez‐Barquero, J. L. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2006.08.005 · Cited by 55 · see citing works

Genetic and Environmental Influences on Pro-Inflammatory Monocytes in Bipolar Disorder

Padmos, R. C., van Baal, G. C. M., Vonk, R., Wijkhuijs, A. J. M., Kahn, R. S., Nolen, W. A., & Drexhage, H. A. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.116 · Cited by 55 · see citing works

Increased levels of CD8+ and CD4 + 45RA + lymphocytes in schizophrenic patients

Cazzullo, C. L., Saresella, M., Roda, K., Calvo, M. G., Bertrando, P., Doria, S. M. D. S., Clerici, M., SALVAGGIO, A., & Ferrante, P. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00153-9 · Cited by 54 · see citing works

Elevation of cell adhesion molecule immunoreactivity in the anterior cingulate cortex in bipolar disorder

Thomas, A. J., Davis, S., Ferrier, I. N., Kalaria, R. N., & O'Brien, J. T. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.015 · Cited by 53 · see citing works

The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder

Torres, K., Souza, B. R., de Miranda, D. M., Nicolato, R., Neves, F. S., Barros, A. G. A., Dutra, W. O., Gollob, K. J., Corrêa, H., & Romano‐Silva, M. A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.020 · Cited by 52 · see citing works

Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: Association with the metabolic syndrome in patients?

Drexhage, R. C., Padmos, R. C., de Wit, H., Versnel, M. A., Hooijkaas, H., van der Lely, A. J., van Beveren, N. J. M., DeRijk, R. H., & Cohen, D. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.03.018 · Cited by 49 · see citing works

Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment

Cohen, D., Dekker, J., Peen, J., & Wied, C. C. G. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.09.003 · Cited by 49 · see citing works

Risk variants in the S100B gene predict elevated S100B serum concentrations in healthy individuals

Hohoff, C., Ponath, G. D., Freitag, C., Kästner, F., Krakowitzky, P., Domschke, K., Koelkebeck, K., Kipp, F., von Eiff, C., Deckert, J., et al. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30950 · Cited by 40 · see citing works

Expression of neuronal calcium sensor-1 (NCS-1) is decreased in leukocytes of schizophrenia and bipolar disorder patients

Torres, K., Souza, B. R., de Miranda, D. M., Sampaio, A. M., Nicolato, R., Neves, F. S., Barros, A. G. A., Dutra, W. O., Gollob, K. J., Corrêa, H., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.011 · Cited by 38 · see citing works

Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFNα-induced depression

Hauser, P. (2004) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2003.12.005 · Cited by 37 · see citing works

Antigen-Presenting Dendritic Cells as Regulators of the Growth of Thyrocytes: A Role of Interleukin-1β and Interleukin-6*

Simons, P. J., Delemarre, F. G. A., & Drexhage, H. A. (1998) · Endocrinology · doi:10.1210/endo.139.7.6110 · Cited by 37 · see citing works

Increased frequency of CD8 positive gamma/delta T-lymphocytes (CD8+γ/δ+) in unmedicated schizophrenic patients: relation to impairment of the blood–brain barrier and HLA-DPA*02011

Müller, N., Schlesinger, B. C., Hadjamu, M., Riedel, M. J., Schwarz, M., Ackenheil, M., Wank, R., & Gruber, R. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00036-x · Cited by 35 · see citing works

ICAM G241A Polymorphism and Soluble ICAM-1 Serum Levels: Evidence for an Active Immune Process in Schizophrenia

Krönig, H., Riedel, M. J., Schwarz, M., Strassnig, M., Möller, H., Ackenheil, M., & Müller, N. (2005) · NeuroImmunoModulation · doi:10.1159/000082364 · Cited by 35 · see citing works

Immune function in mania

Kronfol, Z., & House, J. D. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90204-1 · Cited by 35 · see citing works

Serum Interleukin 1α and Interleukin 2 Levels in Patients with Schizophrenia

Ebrinç, S., Top, C., Öncül, O., Başoğlu, C., Çavuşlu, Ş., & Çetin, M. (2002) · Journal of International Medical Research · doi:10.1177/147323000203000313 · Cited by 32 · see citing works

Relation between the tumor necrosis factor-alpha (TNF-alpha) gene and protein expression, and clinical, biochemical, and genetic markers: age, body mass index and uric acid are independent predictors for an elevated TNF-alpha plasma level in a complex risk model.

Schulz, S., Schagdarsurengin, U., Süß, T., Müller‐Werdan, U., Werdan, K., & Gläser, C. (2004) · PubMed · Cited by 30 · see citing works

High-quality remission: potential benefits of the melatonergic approach for patients with major depressive disorder

Lam, R. W. M. (2007) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000277959.60604.d1 · Cited by 30 · see citing works

Zytokinnetzwerke bei Patienten mit Schizophrenie und ihre Bedeutung für die Pathophysiologie der Erkrankung

Schuld, A., Hinze‐Selch, D., & Pollmächer, T. (2004) · Der Nervenarzt · doi:10.1007/s00115-003-1599-x · Cited by 27 · see citing works

Plasma cytokine response to surgical stress in schizophrenic patients

Kudoh, A., Sakai, T., Ishihara, H., & MATSUKI, A. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01581.x · Cited by 26 · see citing works

Racial Variation in Serum-Soluble Interleukin-2 Receptor Levels: A Population-Based Study of Healthy Smokers and Nonsmokers

Tollerud, D. J., Kurman, C. C., Nelson, D. L., Brown, L. M., Maloney, E. M., & Blattner, W. A. (1994) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1994.1040 · Cited by 25 · see citing works

Postoperative confusion in schizophrenic patients is affected by interleukin-6

Kudoh, A., Takase, H., Takahira, Y., Katagai, H., & Takazawa, T. (2003) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2003.03.008 · Cited by 24 · see citing works

A Functional and Phenotypic Study on Immune Accessory Cells Isolated from the Thyroids of Wistar and Autoimmune-prone BB-DP Rats

Simons, P. J., Delemarre, F. G. A., & Drexhage, H. A. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0438 · Cited by 17 · see citing works

Differential effects on T-cell function following exposure to serum from schizophrenia smokers

Herberth, M., Krzyszton, D. N., Koethe, D., Craddock, M. R., Bulger, E. M., Schwarz, E., Guest, P. C., Leweke, F. M., & Bahn, S. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.120 · Cited by 15 · see citing works

When Immunization Leads to Autoimmunity: Chronic Inflammation as a Result of Thymic and Mucosal Dysregulation in IL-2 Knock-out Mice

Ehrhardt, R. O., & Ludviksson, B. R. (1999) · International Reviews of Immunology · doi:10.3109/08830189909088500 · Cited by 7 · see citing works

Erratum: Differential effects on T-cell function following exposure to serum from schizophrenia smokers

Herberth, M., Krzyszton, D. N., Koethe, D., Craddock, M. R., Bulger, E., Schwarz, E., Guest, P. C., Leweke, F. M., & Bahn, S. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.137 · Cited by 1 · see citing works

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178 · see citing works

Maternal immune activation and abnormal brain development across CNS disorders

Knuesel, I., Chicha, L., Britschgi, M., Schobel, S. A., Bodmer, M., Hellings, J. A., Toovey, S., & Prinssen, E. P. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.187 · Cited by 880 · see citing works

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?

Steiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568 · see citing works

<i>N</i>-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Dean, O., Giorlando, F., & Berk, M. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100057 · Cited by 494 · see citing works

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463 · see citing works

Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis

Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402 · see citing works

The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes

Beumer, W., Gibney, S. M., Drexhage, R. C., Pont-Lezica, L., Doorduin, J., Klein, H. C., Steiner, J., Connor, T. J., Harkin, A., Versnel, M. A., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212100 · Cited by 347 · see citing works

Neuroinflammation in schizophrenia especially focused on the role of microglia

Monji, A., Kato, T. A., Mizoguchi, Y., Horikawa, H., Seki, Y., Kasai, M., Yamauchi, Y., Yamada, S., & Kanba, S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.002 · Cited by 314 · see citing works

Developmental neuroinflammation and schizophrenia

Meyer, U. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.11.003 · Cited by 300 · see citing works

Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond

Meyer, U., Schwarz, M., & Müller, N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.003 · Cited by 255 · see citing works

Cytokines in bipolar disorder: A systematic review and meta-analysis

Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256 · see citing works

Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling

Severance, E. G., Yolken, R. H., & Eaton, W. W. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.027 · Cited by 256 · see citing works

Dose-dependent effects of endotoxin on neurobehavioral functions in humans

Grigoleit, J.-S., Kullmann, J. S., Wolf, O. T., Hammes, F., Wegner, A., Jablonowski, S., Engler, H., Gizewski, E., Oberbeck, R., & Schedlowski, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028330 · Cited by 241 · see citing works

Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia

Severance, E. G., Gressitt, K. L., Stallings, C. R., Origoni, A. E., Khushalani, S., Leweke, F. M., Dickerson, F. B., & Yolken, R. H. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.018 · Cited by 243 · see citing works

Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder

Fillman, S. G., Sinclair, D., Fung, S. J., Webster, M. J., & Shannon Weickert, C. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.8 · Cited by 226 · see citing works

Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects

Miller, B. J., Gassama, B., Sebastian, D., Buckley, P. F., & Mellor, A. L. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.007 · Cited by 232 · see citing works

The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis

Perry, B. I., McIntosh, G., Weich, S., Singh, S. P., & Rees, K. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30262-0 · Cited by 227 · see citing works

The “psychomicrobiotic”: targeting microbiota in major psychiatric disorders: a systematic review

Fond, G., Boukouaci, W., Chevalier, G., Regnault, A., Eberl, G., Hamdani, N., Dickerson, F., Macgregor, A., Boyer, L., Dargel, A., et al. (2015) · Pathologie Biologie · doi:10.1016/j.patbio.2014.10.003 · Cited by 219 · see citing works

Endotoxin-induced experimental systemic inflammation in humans: A model to disentangle immune-to-brain communication

Schedlowski, M., Engler, H., & Grigoleit, J.-S. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.09.015 · Cited by 195 · see citing works

Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: Further evidence for disease course-related immune alterations?

Busse, S., Busse, M., Schiltz, K., Bielau, H., Gos, T., Brisch, R., Mawrin, C., Schmitt, A., Jordan, W., Müller, U., et al. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.08.005 · Cited by 195 · see citing works

Novel therapeutic targets in depression: Minocycline as a candidate treatment

Soczynska, J. K., Mansur, R. B., Brietzke, E. M., Swardfager, W., Kennedy, S. H., Woldeyohannes, H. O., Powell, A. M., Manierka, M. S., & McIntyre, R. S. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.026 · Cited by 190 · see citing works

Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment

de Witte, L. D., Tomasik, J., Schwarz, E., Guest, P. C., Rahmoune, H., Kahn, R. S., & Bahn, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.02.005 · Cited by 188 · see citing works

Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis

Wang, L., Wang, R., Liu, L., Qiao, D., Baldwin, D. S., & Hou, R. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.021 · Cited by 192 · see citing works

Inflammation in schizophrenia: A question of balance

Leza, J. C., García‐Bueno, B., Bioque, M., Arango, C., Parellada, M., Kim, Q., O’Donnell, P., & Bernardo, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.014 · Cited by 183 · see citing works

Immune System Disturbances in Schizophrenia

Horváth, S., & Mirnics, K. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.010 · Cited by 177 · see citing works

Effectiveness and tolerance of anti‐inflammatory drugs' add‐on therapy in major mental disorders: a systematic qualitative review

Fond, G. B., Hamdani, N., Kapczinski, F. P., Boukouaci, W., Drancourt, N., Dargél, A., Oliveira, J., Guen, E. L., Marlinge, E., Tamouza, R., et al. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12211 · Cited by 172 · see citing works

The activation of monocyte and T cell networks in patients with bipolar disorder

Drexhage, R. C., Hoogenboezem, T., Versnel, M. A., Berghout, A., Nolen, W. A., & Drexhage, H. A. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.013 · Cited by 172 · see citing works

An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces

Drexhage, R. C., Hoogenboezem, T. A., Cohen, D., Versnel, M. A., Nolen, W. A., van Beveren, N. J. M., & Drexhage, H. A. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001653 · Cited by 169 · see citing works

Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.

Hope, S., Dieset, I., Agartz, I., Steen, N. E., Ueland, T., Melle, I., Aukrust, P., & Andreassen, O. A. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.08.003 · Cited by 164 · see citing works

Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome

Beumer, W., Drexhage, R. C., de Wit, H., Versnel, M. A., Drexhage, H. A., & Cohen, D. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.04.001 · Cited by 161 · see citing works

Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity

Steiner, J. H., Bogerts, B., Sarnyai, Z., Walter, M., Gos, T., Bernstein, H., & Myint, A.-M. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.583941 · Cited by 159 · see citing works

Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy

Xu, J., Wang, H., Xu, L., Chao, Y., Wang, C., Han, X., Dong, Z., Chang, H., Peng, R., Cheng, Y., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.03.037 · Cited by 154 · see citing works

Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics

Lai, C.-Y., Scarr, E., Udawela, M., Everall, I., Chen, W. J., & Dean, B. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i1.102 · Cited by 153 · see citing works

Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder

Benedetti, F., Poletti, S., Hoogenboezem, T. A., Mazza, E., Ambrée, O., de Wit, H., Wijkhuijs, A. J. M., Locatelli, C., Bollettini, I., Colombo, C., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.047 · Cited by 151 · see citing works

Role of neuro-immunological factors in the pathophysiology of mood disorders

Bhattacharya, A., Derecki, N. C., Lovenberg, T. W., & Drevets, W. C. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4214-0 · Cited by 149 · see citing works

Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities

Savitz, J., Frank, M. B., Victor, T., Bebak, M., Marino, J. H., Bellgowan, P. S. F., McKinney, B. A., Bodurka, J., Kent Teague, T., & Drevets, W. C. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.007 · Cited by 146 · see citing works

Updating the mild encephalitis hypothesis of schizophrenia

Bechter, K. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.019 · Cited by 141 · see citing works

Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment

Xu, Y., Wang, C., Klabnik, J., & Donnell, J. O. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120231448 · Cited by 139 · see citing works

Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder

Hope, S., Ueland, T., Steen, N. E., Dieset, I., Lorentzen, S., Berg, A. O., Agartz, I., Aukrust, P., & Andreassen, O. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.12.023 · Cited by 131 · see citing works

Inflammatory Biomarkers and Depression

Müller, N., Myint, A.-M., & Schwarz, M. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9210-2 · Cited by 125 · see citing works

Immune System Dysregulation in First-Onset Postpartum Psychosis

Bergink, V., Burgerhout, K. M., Weigelt, K., Pop, V. J. M., de Wit, H., Drexhage, R. C., Kushner, S. A., & Drexhage, H. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.006 · Cited by 120 · see citing works

Mediators of allostasis and systemic toxicity in bipolar disorder.

Grande, I., Magalhães, P., Kunz, M., Vieta, E., & Kapczinski, F. (2012) · Physiology and Behavior · doi:10.1016/j.physbeh.2011.10.029 · Cited by 121 · see citing works

Rapid Treatment Response of Suicidal Symptoms to Lithium, Sleep Deprivation, and Light Therapy (Chronotherapeutics) in Drug-Resistant Bipolar Depression

Benedetti, F., Riccaboni, R., Locatelli, C., Poletti, S., Dallaspezia, S., & Colombo, C. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08455 · Cited by 116 · see citing works

Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients

Myint, A.-M., Schwarz, M., Verkerk, R. M., Mueller, H. H., Zach, J., Scharpé, S., Steinbusch, H. W. M., Leonard, B. E., & Kim, Y. K. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.005 · Cited by 116 · see citing works

Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: Potential role for IL-17 pathway

Dimitrov, D. H., Lee, S., Yantis, J., Valdez, C., Paredes, R. M., Braida, N., Velligan, D. I., & Walss‐Bass, C. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.019 · Cited by 114 · see citing works

Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls

Hope, S., Hoseth, E. Z., Dieset, I., Mørch, R. H., Aas, M., Aukrust, P., Djurovic, S., Melle, I. S., Ueland, T., Agartz, I., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.04.004 · Cited by 114 · see citing works

Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: Comparison with schizophrenia

Altamura, A. C., Buoli, M., & Pozzoli, S. M. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12089 · Cited by 111 · see citing works

Autism and Increased Paternal Age Related Changes in Global Levels of Gene Expression Regulation

Alter, M. D., Kharkar, R., Ramsey, K. E., Craig, D. W., Melmed, R. D., Grebe, T. A., Bay, R. C., Ober‐Reynolds, S., Kirwan, J., Jones, J. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016715 · Cited by 106 · see citing works

Identification of Subgroups of Schizophrenia Patients With Changes in Either Immune or Growth Factor and Hormonal Pathways

Schwarz, E., van Beveren, N. J. M., Ramsey, J., Leweke, F. M., Rothermundt, M., Bogerts, B., Steiner, J. H., Guest, P. C., & Bahn, S. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt105 · Cited by 104 · see citing works

Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells

Gardiner, E. J., Cairns, M. J., Liu, B., Beveridge, N. J., Carr, V. J., Kelly, B. J., Scott, R. J., & Tooney, P. A. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.11.007 · Cited by 103 · see citing works

Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder

Tsai, S., Chung, K., Wu, J.-Y., Kuo, C., Lee, H., & Huang, S. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.022 · Cited by 102 · see citing works

Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro

Himmerich, H., Bartsch, S., Hamer, H., Mergl, R., Schönherr, J., Petersein, C., Munzer, A., Kirkby, K. C., Bauer, K., & Sack, U. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.07.026 · Cited by 100 · see citing works

Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application

Watkins, C. C., Sawa, A., & Pomper, M. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.119 · Cited by 100 · see citing works

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia

Malan‐Müller, S., Kilian, S., van den Heuvel, L. L., Bardien, S., Asmal, L., Warnich, L., Emsley, R. A., Hemmings, S. M. J., & Seedat, S. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.11.011 · Cited by 98 · see citing works

Chemokines in bipolar disorder: Trait or state?

Barbosa, I. G., Rocha, N. P., Bauer, M. E., de Miranda, A. S., Huguet, R. B., Reis, H. J., Zunszain, P. A., Horowitz, M. A., Pariante, C. M., & Teixeira, A. L. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0327-6 · Cited by 98 · see citing works

Impaired monocyte activation in schizophrenia

Müller, N., Wagner, J. K., Krause, D., Weidinger, E., Wildenauer, A., Obermeier, M., Dehning, S., Gruber, R., & Schwarz, M. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.12.049 · Cited by 97 · see citing works

A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates

Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95 · see citing works

Clinical studies of neuroinflammatory mechanisms in schizophrenia

Watkins, C. C., & Andrews, S. R. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.07.018 · Cited by 96 · see citing works

Applications of blood-based protein biomarker strategies in the study of psychiatric disorders

Chan, M. K., Gottschalk, M. G., Haenisch, F., Tomasik, J., Ruland, T., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.08.002 · Cited by 94 · see citing works

Anti-inflammatory treatment in schizophrenia

Müller, N., Myint, A.-M., Krause, D., Weidinger, E., & Schwarz, M. J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.008 · Cited by 89 · see citing works

Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia

Brambilla, P., Bellani, M., Isola, M., Bergami, A., Marinelli, V, Dusi, N., Rambaldelli, G., Tansella, M., Maria Finardi, A., Martino, G., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.46 · Cited by 86 · see citing works

Inflammatory response in heroin addicts undergoing methadone maintenance treatment

Chan, Y.-Y., Yang, S., Lin, J., Chang, J.-L., Lin, J., & Lo, W. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.12.053 · Cited by 88 · see citing works

Inflammation in Schizophrenia

Müller, N., Myint, A.-M., & Schwarz, M. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-398314-5.00003-9 · Cited by 84 · see citing works

Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders

Sethi, R., Gómez‐Coronado, N., Walker, A. J., Robertson, O. D., Agustini, B., Berk, M., & Dodd, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00605 · Cited by 88 · see citing works

The relationship between interleukin‐1 receptor antagonist and cognitive function in older adults with bipolar disorder

Lotrich, F. E., Butters, M. A., Aizenstein, H. J., Marron, M. M., Reynolds, C. F., & Gildengers, A. G. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4048 · Cited by 83 · see citing works

Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?

Busse, M., Busse, S., Myint, A., Gos, T., Dobrowolny, H., Müller, U. J., Bogerts, B., Bernstein, H., & Steiner, J. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0562-0 · Cited by 74 · see citing works

Immune system and glucose metabolism interaction in schizophrenia: A chicken–egg dilemma

Steiner, J. H., Bernstein, H., Schiltz, K., Müller, U., Westphal, S., Drexhage, H. A., & Bogerts, B. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.09.016 · Cited by 79 · see citing works

Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile

Kaddurah-Daouk, R., Yuan, P., Boyle, S. H., Matson, W., Wang, Z., Zeng, Z. B., Zhu, H., Dougherty, G. G., Yao, J. K., Chen, G., et al. (2012) · Scientific Reports · doi:10.1038/srep00667 · Cited by 76 · see citing works

Adverse childhood experiences influence white matter microstructure in patients with bipolar disorder

Benedetti, F., Bollettini, I., Radaelli, D., Poletti, S., Locatelli, C., Falini, A., Smeraldi, E., & Colombo, C. (2014) · Psychological Medicine · doi:10.1017/s0033291714000506 · Cited by 73 · see citing works

Role of Neuro-Immunological Factors in the Pathophysiology of Mood Disorders: Implications for Novel Therapeutics for Treatment Resistant Depression

Bhattacharya, A., & Drevets, W. C. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_43 · Cited by 76 · see citing works

Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial

Savitz, J. B., Preskorn, S., Teague, T. K., Drevets, D. A., Yates, W. R., & Drevets, W. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000643 · Cited by 72 · see citing works

Anti-inflammatory signaling in schizophrenia

Meyer, U. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.014 · Cited by 72 · see citing works

The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder

Kim, H. K., Chen, W., & Andreazza, A. C. (2015) · Neural Plasticity · doi:10.1155/2015/408136 · Cited by 71 · see citing works

Prenatal maternal immune disruption and sex-dependent risk for psychoses

Goldstein, J. M., Cherkerzian, S., Seidman, L. J., Donatelli, J.-A. L., Remington, A., Tsuang, M. T., Hornig, M., & Buka, S. L. (2014) · Psychological Medicine · doi:10.1017/s0033291714000683 · Cited by 71 · see citing works

The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review

van den Ameele, S., van Diermen, L., Staels, W., Coppens, V., Dumont, G., Sabbe, B., & Morrens, M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.016 · Cited by 69 · see citing works

The Neuroimmunology of Schizophrenia

Annya, M., Smyth, Stephen, M., & Lawrie, S. M. (2013) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2013.11.3.107 · Cited by 66 · see citing works

Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy

Gondalia, S. V., Parkinson, L., Stough, C. K. K., & Scholey, A. B. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05248-6 · Cited by 68 · see citing works

Increased prevalence of Chlamydophila DNA in post-mortem brain frontal cortex from patients with schizophrenia

Fellerhoff, B., & Wank, R. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.04.015 · Cited by 65 · see citing works

Role of P2X7 Receptor in an Animal Model of Mania Induced by D-Amphetamine

Gubert, C., Fries, G. R., Pfaffenseller, B., Ferrari, P., Coutinho‐Silva, R., Morrone, F. B., Kapczinski, F. P., & Battastini, A. M. O. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-9031-z · Cited by 64 · see citing works

Priming of Metabolic Dysfunctions by Prenatal Immune Activation in Mice: Relevance to Schizophrenia

Pacheco‐López, G., Giovanoli, S., Langhans, W., & Meyer, U. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr178 · Cited by 65 · see citing works

Clinical Staging in Psychiatry

Berger, G. (2019) · Cambridge University Press eBooks · doi:10.1017/9781139839518 · Cited by 64 · see citing works

Affective Immunology: The Crosstalk Between Microglia and Astrocytes Plays Key Role?

Yang, L., Zhou, Y., Jia, H., Qi, Y., Tu, S., & Shao, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01818 · Cited by 64 · see citing works

Down-regulation of inflammation-protective microRNAs 146a and 212 in monocytes of patients with postpartum psychosis

Weigelt, K., Bergink, V., Burgerhout, K. M., Pescatori, M., Wijkhuijs, A. J. M., & Drexhage, H. A. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.12.018 · Cited by 60 · see citing works

Lipopolysaccharide-induced experimental immune activation does not impair memory functions in humans

Grigoleit, J.-S., Oberbeck, J. R., Lichte, P., Kobbe, P., Wolf, O. T., Montag, T., Rey, A. D., Gizewski, E. R., Engler, H., & Schedlowski, M. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.09.011 · Cited by 59 · see citing works

IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia

Severance, E. G., Gressitt, K. L., Alaedini, A., Rohleder, C., Enning, F., Bumb, J. M., Müller, J. K., Schwarz, E., Yolken, R. H., & Leweke, F. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.09.009 · Cited by 59 · see citing works

The common pathophysiology underlying the metabolic syndrome, schizophrenia and depression. A review

Kučerová, J., Babinská, Z., Horská, K., & Kotolová, H. (2014) · Biomedical Papers · doi:10.5507/bp.2014.060 · Cited by 59 · see citing works

Inflammation in psychotic disorders: A population-based study

Suvisaari, J., Loo, B.-M., Saarni, S. E., Haukka, J. K., Perälä, J., Saarni, S. I., Viertiö, S., Partti, K., Lönnqvist, J. K., & Jula, A. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.07.006 · Cited by 57 · see citing works

Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine

Valvassori, S. S., Tonin, P. T., Varela, R. B., Carvalho, A. F., Mariot, E., Amboni, R. T., Bianchini, G., Andersen, M. L., & Quevedo, J. (2015) · Bipolar Disorders · doi:10.1111/bdi.12299 · Cited by 57 · see citing works

Morphological features of microglial cells in the hippocampal dentate gyrus of Gunn rat: a possible schizophrenia animal model

Liaury, K., Miyaoka, T., Tsumori, T., Furuya, M., Wake, R., Ieda, M., Tsuchie, K., Taki, M., Ishihara, K., Tanra, A. J., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-56 · Cited by 56 · see citing works

Experimental human endotoxemia enhances brain activity during social cognition

Kullmann, J. S., Grigoleit, J., Wolf, O. T., Engler, H., Oberbeck, R., Elsenbruch, S., Forsting, M., Schedlowski, M., & Gizewski, E. R. (2013) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nst049 · Cited by 53 · see citing works

Sleep and inflammatory markers in different psychiatric disorders

Krysta, K., Krzystanek, M., Bratek, A., & Krupka-Matuszczyk, I. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-015-1492-3 · Cited by 53 · see citing works

Migration and psychotic disorders

Veling, W., & Susser, E. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.91 · Cited by 54 · see citing works

Monocyte activation, brain‐derived neurotrophic factor ( BDNF ), and S100B in bipolar offspring: a follow‐up study from adolescence into adulthood

Mesman, E., Hillegers, M. H. J., Ambrée, O., Arolt, V., Nolen, W. A., & Drexhage, H. A. (2014) · Bipolar Disorders · doi:10.1111/bdi.12231 · Cited by 52 · see citing works

Chronobiology of Bipolar Disorder: Therapeutic Implication

Dallaspezia, S., & Benedetti, F. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0606-9 · Cited by 53 · see citing works

Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine

O’Connell, K. E., Thakore, J. H., & Dev, K. K. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.020 · Cited by 49 · see citing works

Glucose metabolism dysregulation at the onset of mental illness is not limited to first episode psychosis: A systematic review and meta‐analysis

Küçükgöncü, S., Košir, U., Zhou, E. K., Sullivan, E. L., Srihari, V. H., & Tek, C. (2018) · Early Intervention in Psychiatry · doi:10.1111/eip.12749 · Cited by 50 · see citing works

Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients

Gos, T., Myint, A.-M., Schiltz, K., Meyer-Lotz, G., Dobrowolny, H., Busse, S., Müller, U. J., Mawrin, C., Bernstein, H.-G., Bogerts, B., et al. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.05.012 · Cited by 49 · see citing works

Systemic Cell Adhesion Molecules in Severe Mental Illness: Potential Role of Intercellular CAM-1 in Linking Peripheral and Neuroinflammation

Sheikh, M. A., O’Connell, K. S., Lekva, T., Szabó, A., Akkouh, I. A., Osete, J. R., Agartz, I., Engh, J. A., Andreou, D., Boye, B., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.06.029 · Cited by 49 · see citing works

Modulation of Cytokine Production by Drugs with Antiepileptic or Mood Stabilizer Properties in Anti-CD3- and Anti-CD40-Stimulated BloodIn Vitro

Himmerich, H., Bartsch, S., Hamer, H. M., Mergl, R., Schönherr, J., Petersein, C., Munzer, A., Kirkby, K. C., Bauer, K., & Sack, U. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/806162 · Cited by 47 · see citing works

Exercise-induced modulation of histone H4 acetylation status and cytokines levels in patients with schizophrenia

Lavratti, C., Dorneles, G. P., Pochmann, D., Peres, A., Bard, A. L., Schipper, L. L., Lago, P. D., Wagner, L. C., & Elsner, V. R. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.10.021 · Cited by 48 · see citing works

Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients

Drexhage, R. C., van der Heul-Nieuwenhuijsen, L., Padmos, R. C., van Beveren, N. J. M., Cohen, D., Versnel, M. A., Nolen, W. A., & Drexhage, H. A. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000799 · Cited by 152 · see citing works

An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces

Drexhage, R. C., Hoogenboezem, T. A., Cohen, D., Versnel, M. A., Nolen, W. A., van Beveren, N. J. M., & Drexhage, H. A. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001653 · Cited by 169 · see citing works

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor

Hope, S., Melle, I. S., Aukrust, P., Steen, N. E., Birkenaes, A. B., Lorentzen, S., Agartz, I., Ueland, T., & Andreassen, O. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00757.x · Cited by 152 · see citing works

Increased proportions of circulating pro‐inflammatory monocytes and macrophages expressing toll‐like receptor 4 in individuals with schizophrenia and bipolar disorder receiving medication

Tsai, S., Sajatovic, M., Chen, P., Huang, Y., & Chung, K. (2023) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13599 · Cited by 4 · see citing works

Similar immune profile in bipolar disorder and schizophrenia:selective increase in soluble tumor necrosis factor receptor 1 and von Willebrand factor

Hope, S. (2009)